X3 Holdings Co., Ltd. (NASDAQ:XTKG) announced it has signed a strategic agreement with an artificial intelligence healthcare technology company to support the global rollout of an AI-powered healthcare smartwatch, marking the company’s expansion into the digital health sector.
Under the partnership, X3 Holdings will assist with international commercialization and operational deployment of the wearable device, leveraging its experience in global digital operations, system integration and cross-border market execution.
The smartwatch is designed as an AI-enabled neuro-digital health platform aimed at shifting healthcare toward proactive monitoring and preventive management. The device focuses on emotional and neurological balance — areas the company said are often underrepresented in traditional healthcare models — through continuous monitoring and adaptive regulation intended to support long-term physiological stability.
At the core of the technology is a non-invasive brainwave sensing chip combined with digital frequency modulation capabilities. The system targets 27 functional brain-related points associated with language, emotion and social interaction, enabling real-time signal capture and automated adjustments through a closed-loop process of monitoring, analysis and feedback without the use of invasive procedures or pharmaceuticals.
The wearable operates on a large-scale health data platform built from approximately 7 million user records and 25,000 physiological indicators. Data collected continuously are processed through cloud-based AI analytics to generate personalized health insights and dynamically refine intervention parameters, creating an automated monitor–analyze–adjust digital health framework.
Beyond neurological tracking, the platform is intended to support broader applications such as emotional wellness management, cognitive support, chronic discomfort monitoring and rehabilitation-focused use cases, positioning the device within preventive and adaptive healthcare strategies.
According to the company, clinical validation data demonstrate strong effectiveness across multiple neurological and behavioral intervention scenarios, showing measurable functional improvements following sustained device use.
The smartwatch technology is developed by X3 Holdings’ partner, which specializes in non-invasive brain–computer interface systems and digital neuro-health technologies, combining proprietary chip design, signal processing algorithms and large-scale health data modeling into a unified wearable solution.
Through the collaboration, X3 Holdings will focus on product positioning, distribution coordination and operational infrastructure across international markets. The company expects its first service contract tied to the partnership to begin generating revenue in March 2026, subject to final commercial agreements and rollout schedules.
“AI healthcare and intelligent wearables represent one of the most dynamic growth frontiers at the intersection of artificial intelligence, neurotechnology, and digital health infrastructure,” said Stewart Lor, CEO of X3 Holdings. “As global demand accelerates for data-driven preventive care and personalized health analytics, we believe this strategic move positions us to participate in a high-growth, innovation-led market. By integrating advanced sensing technologies with our global operational execution, we are building a scalable AI healthcare platform that complements and strengthens our broader AI engine.”
About X3 Holdings
X3 Holdings Co., Ltd. is a global provider of AI solutions and digital services operating across sectors including global trade, gaming, education and healthcare. Founded in 1997 and headquartered in Singapore, the company maintains subsidiaries and operations worldwide.